Your browser doesn't support javascript.
loading
Risk of fetal or neonatal death or neonatal intensive care unit admission associated with gadolinium magnetic resonance imaging exposure during pregnancy.
Winterstein, Almut G; Thai, Thuy N; Nduaguba, Sabina; Smolinski, Nicole E; Wang, Xi; Sahin, Leyla; Krefting, Ira; Gelperin, Kate; Bird, Steven T; Rasmussen, Sonja A.
Afiliação
  • Winterstein AG; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL; Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL; Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, U
  • Thai TN; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL; Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL; Faculty of Pharmacy, Ho Chi Minh City University of Technology (HUTECH), Ho Chi Minh City, Vietnam.
  • Nduaguba S; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL; Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL.
  • Smolinski NE; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL; Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL.
  • Wang X; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL.
  • Sahin L; Division of Pediatrics and Maternal Health, Office of New Drugs, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, MD.
  • Krefting I; Division of Imaging and Radiation Medicine, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
  • Gelperin K; Division of Epidemiology, Office of Surveillance and Epidemiology, CDER, FDA, Silver Spring, MD.
  • Bird ST; Division of Epidemiology, Office of Surveillance and Epidemiology, CDER, FDA, Silver Spring, MD.
  • Rasmussen SA; Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, FL; Department of Epidemiology, College of Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, FL; Departments of Pediatrics, College of Medicine, University of Florida, G
Am J Obstet Gynecol ; 228(4): 465.e1-465.e11, 2023 04.
Article em En | MEDLINE | ID: mdl-36241080
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Morte Perinatal Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Tardios da Exposição Pré-Natal / Morte Perinatal Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Revista: Am J Obstet Gynecol Ano de publicação: 2023 Tipo de documento: Article